• Modules
    Modules
    • The Immune System
      The Immune System
      • Overview/Key Objectives
      • The Immune System
      • Components of the Immune System
      • The Innate vs. Adaptive Immune Response
      • Inflammation
      • Adaptive Immunity – Humoral and Cellular Immunity
      • Activated vs. Anergic Immune Functionality
      • References
      • Assessment Questions
    • Cancer and the Immune System: History and Theory
      Cancer and the Immune System: History and Theory
      • Overview/Key Objectives
      • Brief History of Cancer Immunotherapy Approaches and Theories
      • A Hallmark of Cancer – Evasion of Immune Destruction
      • Immuno-oncology Theories – Immunoediting and Immune Surveillance
      • Cancer-Immunity Cycle
      • References
      • Assessment Questions
    • Clinical Indications
      Clinical Indications
      • Overview/Key Objectives
      • Breast Cancer
      • Melanoma
      • Colorectal Cancer
      • Gastric/Gastroesophageal Junction Cancer
      • Lung Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Prostate Cancer
      • Cervical Cancer
      • B-Cell Non-Hodgkin Lymphoma
      • Classical Hodgkin Lymphoma
      • Acute Lymphoblastic Leukemia
      • Anaplastic Large-Cell Lymphoma
      • Multiple Myeloma
      • Merkel Cell Carcinoma
      • Summary
      • References
      • Assessment Questions
    • Immune System Signaling Pathways
      Immune System Signaling Pathways
      • Overview/Key Objectives
      • T Cell Signaling
      • Natural Killer Cell Signaling
      • B7 Family of Ligands
      • Inflammation
      • Inhibitory Signaling Pathways
      • References
      • Assessment Questions
    • Immunotherapies
      Immunotherapies
      • Overview/Key Objectives
      • Non-targeted (Non-specific) Immunotherapies
      • Targeted Immunotherapies: Monoclonal Antibodies, Checkpoint Inhibitors, Therapeutic Vaccines
      • Targeted Immunotherapies: Adoptive Cell Therapies, Oncolytic Virus Therapy
      • Single vs. Combination Immunotherapies
      • References
    • Immunotherapy: Adverse Events
      Immunotherapy: Adverse Events
      • Overview/Key Objectives
      • Cardiovascular
      • Dermatologic
      • Endocrine
      • Endocrine cont
      • Gastrointestinal
      • Cardiovascular
      • Pulmonary
      • Renal
      • Cardiovascular
      • Neurologic Conditions
      • Summary
      • References
      • Assessment Questions
    • Adverse Events
      Adverse Events
      • Overview/Key Objectives
      • Rituximab
      • Trastuzumab
      • Alemtuzumab
      • Ibritumomab Tiuxetan
      • Cetuximab
      • Bevacizumab
      • Panitumumab
      • Recombinant HPV vaccines
      • Ofatumumab
      • Sipuleucel-T
      • Peginterferon alfa-2b
      • Ipilimumab
      • Brentuximab vedotin
      • Pertuzumab
      • Ado-trastuzumab emtansine
      • Obinutuzumab
      • Blinatumomab
      • Nivolumab
      • Pembrolizumab
      • Ramucirumab
      • Talimogene laherparepvec
      • Daratumumab
      • Elotuzumab
      • Atezolizumab
      • References
      • Assessment Questions
  • Quizzes
  • Tumor Boards
  • Videos
  • About
 Visit Healio.com
Learn Immuno-Oncology
  • Modules 
    • The Immune System
      • Overview/Key Objectives
      • The Immune System
      • Components of the Immune System
      • The Innate vs. Adaptive Immune Response
      • Inflammation
      • Adaptive Immunity – Humoral and Cellular Immunity
      • Activated vs. Anergic Immune Functionality
      • References
      • Assessment Questions
    • Cancer and the Immune System: History and Theory
      • Overview/Key Objectives
      • Brief History of Cancer Immunotherapy Approaches and Theories
      • A Hallmark of Cancer – Evasion of Immune Destruction
      • Immuno-oncology Theories – Immunoediting and Immune Surveillance
      • Cancer-Immunity Cycle
      • References
      • Assessment Questions
    • Clinical Indications
      • Overview/Key Objectives
      • Breast Cancer
      • Melanoma
      • Colorectal Cancer
      • Gastric/Gastroesophageal Junction Cancer
      • Lung Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Prostate Cancer
      • Cervical Cancer
      • B-Cell Non-Hodgkin Lymphoma
      • Classical Hodgkin Lymphoma
      • Acute Lymphoblastic Leukemia
      • Anaplastic Large-Cell Lymphoma
      • Multiple Myeloma
      • Merkel Cell Carcinoma
      • Summary
      • References
      • Assessment Questions
    • Immune System Signaling Pathways
      • Overview/Key Objectives
      • T Cell Signaling
      • Natural Killer Cell Signaling
      • B7 Family of Ligands
      • Inflammation
      • Inhibitory Signaling Pathways
      • References
      • Assessment Questions
    • Adverse Events
      • Overview/Key Objectives
      • Rituximab
      • Trastuzumab
      • Alemtuzumab
      • Ibritumomab Tiuxetan
      • Cetuximab
      • Bevacizumab
      • Panitumumab
      • Recombinant HPV vaccines
      • Ofatumumab
      • Sipuleucel-T
      • Peginterferon alfa-2b
      • Ipilimumab
      • Brentuximab vedotin
      • Pertuzumab
      • Ado-trastuzumab emtansine
      • Obinutuzumab
      • Blinatumomab
      • Nivolumab
      • Pembrolizumab
      • Ramucirumab
      • Talimogene laherparepvec
      • Daratumumab
      • Elotuzumab
      • Atezolizumab
      • References
      • Assessment Questions
  • Quizzes
  • Tumor Boards
  • Videos
  • About
  •  
  • Login
  • Register
  • My Account
  • My Curriculum
  • Log Out
 Visit Healio.com
Learn Immuno-Oncology
  1. Healio
  2. Hematology/Oncology
  3. Learn Immuno-Oncology
  4. Tumor Boards

Tumor BoardssTumor Boards

Head and Neck Cancer

START 

Non-Small Cell Lung Cancer

START 

Melanoma Skin Cancer

START 
Expert Perspectives
Follow Healio

 Tell us what you think about Healio.com »

  Help
Sign Up for Email

Get the latest news and education delivered to your inbox

Notice

  • Account Information
  • My Saved
  • Website Registration
  • Login
  • Log Out
  • Update Publication Mailing Address
  • Subscribe or Buy
  • Institutional and Library Subscriptions
  • My Account
  • Email Subscriptions and Alerts
  • Help

©2023 Healio All Rights Reserved.

  • Healio.com
  • Feedback
  • The Healio Network
  • Publications
  • Contact the News Desk
  • About the Wyanoke Group
  • Healio Jobs
  • Advertising Information
  • Reprints
  • Sitemap
  • Legal
  • Medical Disclaimer
  • Privacy Policy
  • Do Not Sell My Personal Information
  • Editorial Policy and Philosophy
  • Terms and Conditions
  • Permissions
Follow Healio

 Tell us what you think about Healio.com »

Sign Up for Email

Get the latest news and education delivered to your inbox

Notice

Account Information

  • My Saved
  • Website Registration
  • Login
  • Log Out
  • Update Publication Mailing Address
  • Subscribe or Buy
  • Institutional and Library Subscriptions
  • My Account
  • Email Subscriptions and Alerts
  • Help

Healio.com

  • Feedback
  • The Healio Network
  • Publications
  • Contact the News Desk
  • About the Wyanoke Group
  • Healio Jobs
  • Advertising Information
  • Reprints
  • Sitemap

Legal

  • Medical Disclaimer
  • Privacy Policy
  • Do Not Sell My Personal Information
  • Editorial Policy and Philosophy
  • Terms and Conditions
  • Permissions

©2023 Healio All Rights Reserved.

Welcome to Learn Immuno-Oncology

Learn. Research. Collaborate.

Begin your journey with Learn Immuno-Oncology.
Test your knowledge and determine where to start.

Notice